Our results are applicable to other oncogenic ES fusion-proteins driven by EWSR1, as genetic or pharmacological inhibition of C1GALT1 also decreases cell viability and tumor growth of ES cells that harbor an EWSR1::ERG fusion. Here, C1GALT1 is linked to neoplasm.